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Abstract
 Introduction—Investigations of the effects of occupational exposure to lead on the 
concentrations of thyroid hormones in the blood have not produced consistent results. A meta-
analysis was performed to assess the effect of occupational exposure to lead on thyroid hormone 
concentrations using the results from published studies.
 Methods—Group means from studies of the thyroid function of persons occupationally 
exposed to lead were used in a meta-analysis. Differences between the control and exposed 
groups, and the slopes between thyroid hormone concentrations and log10 blood lead 
concentrations or duration of exposure to lead were estimated using mixed models. The hormones 
analyzed were thyroid stimulating hormone, total and free thyroxine, and total and free 
triiodothyronine.
 Results—No differences in mean thyroid hormone concentrations were found between the 
exposed and control groups. No relationships were found between blood lead or the duration of 
exposure to lead and thyroid hormone concentrations.
 Conclusion—The results of the analysis do not provide evidence for an effect of occupational 
lead exposure on thyroid function in men.
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 INTRODUCTION
There are few reviews and no meta-analyses of the effects of occupational exposure to lead 
on the thyroid and on the concentrations of thyroid hormones in the blood.
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An editorial on occupational and environmental diseases of the endocrine system [Cohen 
and Felig 1984] indicated that occupational exposure to lead may induce hypothyroidism by 
acting on the hypothalamus and pituitary, and that the effect of lead may vary by race. These 
conclusions were based on one study [Robins, et al. 1983].
In a review of the effect of lead on the thyroid, Łasisz, Zdrojewicz, and Marcinkowski 
[1992] concluded that the hypothyroidism found in workers exposed to lead may be 
evidence of a negative effect of lead on thyroid function.
Doumouchtsis, Doumouchtsis, Doumouchtsis, and Perrea [2009] reviewed occupational and 
animal studies, and concluded that lead appears to affect the hypothalamic-pituitary-thyroid 
axis and that lead influences thyroid hormone kinetics in a pattern that is inconclusive.
In a review of the effect of environmental pollutants on the thyroid, Pearce and Braverman 
[2009], citing studies of occupational exposures, concluded that lead may adversely affect 
the pituitary–thyroid axis by way of an unknown mechanism.
Investigations of the effects of occupational exposure to lead on the concentrations of 
thyroid hormones in the blood have not produced consistent results. For example, Robins, 
Cullen, Connors, and Kayne [1983] found an inverse relationship between free thyroxine 
and blood lead concentrations in 47 men that worked in a brass foundry, while Refowitz 
[1984] found no such relationship in 58 men working at a secondary copper smelter.
The purpose of the meta-analysis reported here was to assess the effect of occupational 
exposure to lead on thyroid hormone concentrations. The results from published 
occupational studies were used. Differences between control and exposed groups, and slopes 
between thyroid hormone concentrations and the log base 10 blood lead concentrations or 
duration of exposure to lead were estimated. Means from published studies were used. The 
hormones that were analyzed included thyroid stimulating hormone, total and free thyroxine, 
and total and free triiodothyronine
 MATERIALS AND METHODS
 Studies
Studies were identified by searching the reference sections of review articles and the papers 
describing individual studies. Searches were made on PubMed combining the terms ‘blood 
lead’ and either ‘thyroid’, ‘thyroxine’, or ‘triiodothyronine’. The last search was made in 
April 3, 2014. Data from 16 studies published in journal articles were used [Andrzejak, et al. 
1996, Bielecka, et al. 1987, Bledsoe, et al. 2011, Cullen, et al. 1984, Dursun and Tutus 1999, 
Erfurth, et al. 2001, Gennart, et al. 1992, Gustafson, et al. 1989, Horiguchi, et al. 1987, 
Liang, et al. 2003, López, et al. 2000, Robins, et al. 1983, Schumacher, et al. 1998, Singh, et 
al. 2000, Tuppurainen, et al. 1988, Yılmaz, et al. 2012]. All the studies that were included 
had subjects that were exposed to lead. All of the exposures were occupational. Persons in 
the control groups were not occupationally exposed to lead. The sample size of a control or 
exposed group had to be greater than one for a group to be included. Case reports of an 
individual were not included. Studies of children or adolescents were not included. Not all 
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studies had measurements of all the thyroid hormones. Eight studies did not have a control 
group. Two studies had more than one exposed group. Demographic information by study is 
presented in a supplementary table (Table SI).
 Blood Lead Measurements
Blood lead was measured in samples of whole blood by atomic absorption 
spectrophotometry in all but one study [Horiguchi, et al. 1987] which used anodic stripping 
voltammetry.
 Thyroid Hormone Measurements
The thyroid hormones measured in the studies include thyroid stimulating hormone, total 
and free thyroxine, and total and free triiodothyronine.
Free thyroxine is a measure of the thyroxine in the blood that is not bound to binding 
proteins, primarily thyroxine-binding globulin, transthyretin (prealbumin), and albumin 
[Schussler 2000]. Total thyroxine is a measure of the bound and unbound thyroxine.
Free triiodothyronine is a measure of the triiodothyronine in the blood that is not bound to 
binding proteins, also primarily thyroxine-binding globulin, transthyretin, and albumin 
[Bartalena and Robbins 1993]. Total triiodothyronine is a measure of the bound and 
unbound triiodothyronine.
Thyroid stimulating hormone, total and free thyroxine, and total and free triiodothyronine 
were all measured in serum by immunoassays, usually from kits supplied by manufacturers. 
In some instances, free thyroxine was not directly measured, but was calculated as the 
estimated free thyroxine [Cullen, et al. 1984, Robins, et al. 1983, Schumacher, et al. 1998] or 
the free thyroxine index [Gennart, et al. 1992].
 Statistical Analysis
The data that were analyzed consisted of group means that were reported in a paper or that 
were calculated from the results of individuals that were reported in a paper. Mixed linear 
models were used to analyze the data. Study was a random variable. A classification variable 
for exposure status or the log base 10 of the mean blood lead concentration was included as 
a fixed effect.
The model used to compare exposed and control groups was
yijk is the mean thyroid hormone measurement. µ is the grand mean. τi is the effect of 
exposure, i = 1 = control, i = 2 = exposed. δj is the random effect of study j. εijk is a random 
error. For most cells, k = 1, however, in some studies there was more than one exposed 
group, so k was greater than one.
The model used for blood lead concentration was
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yij is the mean thyroid hormone measurement. α is the intercept. β is the slope. xi is the log 
base 10 of the mean blood lead concentration of group i. Values from the control and 
exposed groups were included. δj is the random effect of study j. εij is a random error.
The model used for duration of exposure to lead was
yi is the mean thyroid hormone measurement. α is the intercept. β1 is the slope for duration 
of exposure. x1i is the mean duration of exposure in years for group i. Only the exposed 
groups had values. β2 is the slope for age. x2i is the mean age in years for group i. A random 
effect of study was not included because there was not enough data to estimate the effect. εi 
is a random error.
All calculations were done with SAS® (Release 9.3, SAS Institute, Inc., Cary, North 
Carolina). The MIXED procedure was used to estimate the models. The method of 
estimation was residual maximum likelihood.
SigmaPlot® (Version 11.0, Systat Software, Inc., Chicago, Illinois) was used to make the 
graph. Simple linear least squares regression was used to fit the data in the graphs.
 RESULTS
In the 16 studies, there were 366 subjects in the control groups (228 males, 0 females) and 
1,372 subjects in the exposed groups (1,280 males, 15 females). The sex of the subjects was 
not always reported. Race was reported in studies done in the United States, for the control 
groups (51 white, 32 black) and the exposed groups (62 white, 93 black).
Table I shows the means of age, duration of exposure, blood lead, and the thyroid hormone 
measurements for the exposed and control groups. Table II shows the results of the mixed 
models comparing the means of the thyroid hormone measurements of the exposed and 
control groups. No statistically significant differences were found. Table III shows the 
results of the mixed models used to estimate the slopes between the blood lead concentration 
and the thyroid hormone measurements. No statistically significant relationships were found. 
Table IV shows the results of the models used to estimate the slopes between the duration of 
exposure to lead and the thyroid hormone measurements. No statistically significant 
relationships were found.
Figure 1 shows the relationship between the concentration of thyroid stimulating hormone 
and the blood lead concentration. Figure 2 shows the relationships between the 
concentrations of total and free thyroxine and the blood lead concentration. Figure 3 shows 
the relationships between the concentrations of total and free triiodothyronine and the blood 
lead concentration.
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No differences in mean thyroid hormone concentrations were found between the lead 
exposed and control groups. No relationships were found between mean blood lead and 
mean thyroid hormone concentrations. No relationships were found between mean duration 
of exposure to lead and mean thyroid hormone concentrations. Only the exposed groups had 
duration of exposure data. No detected difference or relationship does not necessarily mean 
no effect of lead. It may mean that the number of studies was too small to detect an effect.
Cumulative blood lead concentrations were estimated in four studies [Bledsoe, et al. 2011, 
Erfurth, et al. 2001, Robins, et al. 1983, Schumacher, et al. 1998]. There was not enough 
data to do an analysis of this variable. Bledsoe, Pinkerton, Silver, Deddens, and Biagini 
[2011] found an inverse relationship between the free thyroxine and cumulative blood lead 
concentrations. None of the other studies found a relationship between the cumulative blood 
lead concentration and a thyroid hormone concentration.
 Case Studies
There are case studies of lead poisoning occurring with thyroid dysfunction. Thyroid 
dysfunction may affect the blood lead concentration by affecting bone turnover. In the case 
of hyperthyroidism, lead is probably being released from bone into blood. Thyrotoxicosis 
results in an imbalance between bone resorption and bone formation and results in net bone 
loss [Duncan Bassett and Williams 2003], while hypothyroid patients can have low bone 
turnover and increased cortical thickness [Mosekilde and Melsen 1978]. Lower bone mineral 
density [Nash, et al. 2004] and higher bone turnover [Machida, et al. 2009] have been 
associated with higher blood lead concentrations. Descriptions of the case studies follow.
Kremer and Frank [1955] reported the case of a patient with coexisting myxedema and lead 
poisoning occurring 36 years following exposure to lead. The patient’s blood lead 
measurements were 0.1 mg % (100 µg/dL) and 0.11 mg % (110 µg/dL) on separate days 
prior to being treated for lead poisoning.
Cagin, Diloy-Puray, and Westerman [1978] reported the case of a patient with a retained 
bullet who developed lead poisoning in association with thyrotoxicosis. The patient’s blood 
lead concentration was 107 µg/dL.
Tiwari, Timms, and Rothe [1985] reported the case of a euthyroid woman with lead 
poisoning and hyperthyroxinaemia. Her thyroxine and free thyroxine levels were abnormally 
high and decreased as her blood lead concentration decreased. Her thyroid stimulating 
hormone level and thyroid stimulating hormone response to thyrotropin releasing hormone 
were always normal, as were her concentrations of thyroxine binding globulin and 
tiiodothyronine. The woman’s blood lead level was 64 µg/L.
Goldman, White, Kales, and Hu [1994] reported the case of a woman with thyrotoxicosis 
and an elevated blood lead concentration (53 µg/dL) with no current source of lead exposure. 
She had an elevated bone lead level and increased bone turnover. Her lead poisoning was 
attributed to the release of lead from bone due to hyperthyroidism.
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Klein, Barbé, Pascal, Weryha, and Leclère [1998] reported two cases of hyperthyroidism, an 
82 year old woman with a toxic multinodular thyroid enlargement and a 46 year old man 
with Graves’s disease, both with lead poisoning. Treatment with radioactive iodine cured the 
hypothyroidism and lead poisoning in both patients. They attributed the lead poisoning to 
increased bone turnover and the release of lead from bone due to the hyperthyroidism.
 Clinical Studies
Three clinical studies have led to hypotheses about where and how lead affects thyroid 
function. Two of these studies were used in the meta-analysis.
Sandstead, Stant, Bertram Brill, Arias, and Terry [1969] examined 24 patients with lead 
poisoning, 3 with industrial saturnism and 21 with lead intoxication due to the ingestion of 
illicitly distilled whiskey. They concluded that there was an injury to the iodine trapping and 
concentrating mechanism of the thyroid in these patients. The baseline urine lead 
concentrations of the patients ranged from 10 to 480 µg/L.
Robins, Cullen, Connors, and Kayne [1983] examined 12 patients for lead intoxication at 
their occupational medicine clinic. Seven of those examined had low serum values of 
estimated free thyroxine (< 1.0 ng/dL) and six had low serum values of thyroxine (< 4.6 µg/
dL). None of the patients had characteristic physical findings of myxedema. The blood lead 
levels of the patients ranged from 28 to 117 µg/dL. The seven patients with low estimated 
free thyroxine values were tested one to eight months later after being removed from the 
source of lead exposure or receiving chelation therapy. The blood lead levels of these 
patients decreased 16 to 77 µg/dL. Their estimated free thyroxine levels increased 0.0 to 0.3 
ng/dL and remained below normal.
Cullen, Kayne, and Robins [1984] evaluated seven men with symptomatic lead intoxication. 
The blood lead concentrations of the men ranged from 66 to 139 µg/dL. Two of the men had 
subnormal serum thyroxine and estimated free thyroxine concentrations and one of the men 
had an elevated concentration of thyroid binding globulin and no thyroid stimulating 
hormone response to stimulation by thyroid releasing hormone. The authors concluded that 
the men had defects in thyroid function originating in the pituitary and hypothalamus.
 Environmental and Population Studies
The results of environmental and population studies provide evidence for a decrease in the 
concentrations of serum thyroid stimulating hormone and serum total thyroxine as the blood 
lead concentration increases. The results are not consistent. The average blood lead 
concentration in the studies discussed in this section ranged from 1.3 to 3.1 µg/dL.
Abdelouahab et al. [2008] studied a group of 124 men and 87 women who lived in lakeside 
communities and ate freshwater fish. They found a statistically significant inverse 
relationship between the serum concentration of thyroid stimulating hormone and the whole 
blood lead concentration in women but not in men. Meeker et al. [2009] found that the 
serum concentration of thyroid stimulating hormone decreased as the whole blood lead 
concentration increased in 219 men participating in a study of environmental influences on 
male reproductive health.
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Studies using the population data from the National Health and Nutrition Examination 
Survey have investigated the relationships between the serum concentrations of thyroid 
stimulating hormone, total thyroxine, free thyroxine, total triiodothyronine, and free 
triiodothyronine and the blood lead concentration. The studies used data from the same 
(2007–2008) or overlapping (2007–2010) years.
Yorita Christensen [2013] found a statistically significant inverse relationship between the 
serum concentration of total thyroxine and the blood lead concentration in adults. Mendy, 
Gasana, and Vieira [2013] found a statistically significant inverse relationship between the 
serum concentration of total thyroxine and the blood lead concentration in women, but not in 
men. Luo and Hendryx [2014] found that the concentration of total thyroxine decreased as 
the blood lead concentration increased in men, but not in women. They also found that the 
concentration of free triiodothyronine increased as the blood lead concentration increased in 
men, but not in women. Chen, Kim, Chung, and Dietrich [2013] found no statistically 
significant relationships.
With regard to total thyroxine, Mendy, Gasana, and Vieira [2013] hypothesized that lead 
may reduce the number of proteins that bind to thyroxine and enhance its clearance from the 
blood. Luo and Hendryx [2014] hypothesized that a decrease in total thyroxine may be due 
to lead enhancing the activity of an enzyme, type I deiodinase, which converts thyroxine to 
triiodothyronine.
 CONCLUSION
In the present study, no differences in mean thyroid hormone concentrations were found 
between the lead exposed and control groups. No relationships were found between mean 
blood lead or duration of exposure to lead and mean thyroid hormone concentrations. The 
results of this meta-analysis do not provide evidence for an effect of occupational lead 
exposure on thyroid function in men. Few women were included in the studies, so that a 
conclusion about them is not warranted.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The Thyroid Stimulating Hormone Concentration as a Function of the Log10 Blood Lead 
Concentration (Control Groups: Filled circle, Exposed Groups: Open Circle)
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The Total and Free Thyroxine Concentrations as a Function of the Log10 Blood Lead 
Concentration (Control Groups: Filled Circle, Exposed Groups: Open Circle)
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The Total and Free Triiodothyronine Concentrations as a Function of the Log10 Blood Lead 
Concentration (Control Groups: Filled Circle, Exposed Groups: Open Circle)
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